# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Unlock the potential of AI in pharmaceuticals. With AI's help, the pharma industry could see $60B-$110B in annual economic ...
New Value Generation partnership initiative focused on delivering greater client productivity and innovation with new generativ...
Exane BNP Paribas analyst Stefan Slowinski initiates coverage on IBM (NYSE:IBM) with a Underperform rating and announces Pri...
IBM secures legal victory, saving $1.6 billion in damages awarded to BMC Software Inc. The U.S. 5th Circuit Court of Appeals ru...